Want to create an interactive transcript for this episode?
Podcast: BioCentury This Week
Episode: Ep. 247 - Drug Pricing, Psychedelic Setback & Back to School
Description: The Biden administration has disclosed what Medicare will pay for the first graduates of its drug price negotiation program but biopharma companies, biotech investors and patient advocates are still waiting for the government to reveal how those prices were determined — details that are critical to informing the decisions that will shape the future of medicine. On the latest BioCentury This Week podcast, BioCentury’s editors discuss what last week’s disclosure tells us — and what information is yet to come.They also discuss why psychedelics companies believe they can avoid the hurdles that tripped up Lykos Therapeutics as it sough...